Tackling Threats and Future Problems of Multidrug-Resistant Bacteria

抗生素耐药性 抗生素 抗菌剂 多重耐药 重症监护医学 医学 肺结核 抗药性 生物 微生物学 病理
作者
Eva Medina,Dietmar H. Pieper
出处
期刊:Current Topics in Microbiology and Immunology 卷期号:: 3-33 被引量:117
标识
DOI:10.1007/82_2016_492
摘要

With the advent of the antibiotic era, the overuse and inappropriate consumption and application of antibiotics have driven the rapid emergence of multidrug-resistant pathogens. Antimicrobial resistance increases the morbidity, mortality, length of hospitalization and healthcare costs. Among Gram-positive bacteria, Staphylococcus aureus (MRSA) and multidrug-resistant (MDR) Mycobacterium tuberculosis, and among the Gram-negative bacteria, extended-spectrum beta-lactamase (ESBLs)-producing bacteria have become a major global healthcare problem in the 21st century. The pressure to use antibiotics guarantees that the spread and prevalence of these as well as of future emerging multidrug-resistant pathogens will be a persistent phenomenon. The unfeasibility of reversing antimicrobial resistance back towards susceptibility and the critical need to treat bacterial infection in modern medicine have burdened researchers and pharmaceutical companies to develop new antimicrobials effective against these difficult-to-treat multidrug-resistant pathogens. However, it can be anticipated that antibiotic resistance will continue to develop more rapidly than new agents to treat these infections become available and a better understanding of the molecular, evolutionary and ecological mechanisms governing the spread of antibiotic resistance is needed. The only way to curb the current crisis of antimicrobial resistance will be to develop entirely novel strategies to fight these pathogens such as combining antimicrobial drugs with other agents that counteract and obstruct the antibiotic resistant mechanisms expressed by the pathogen. Furthermore, as many antibiotics are often inappropriately prescribed, a more personalized approach based on precise diagnosis tools will ensure that proper treatments can be promptly applied leading to more targeted and effective therapies. However, in more general terms, also the overall use and release of antibiotics in the environment needs to be better controlled.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ocean关注了科研通微信公众号
1秒前
温大善人完成签到,获得积分10
1秒前
Amb1tionG发布了新的文献求助10
3秒前
3秒前
科研通AI2S应助辰星采纳,获得10
4秒前
ccm应助辰星采纳,获得10
4秒前
卷卷完成签到,获得积分20
4秒前
8秒前
8秒前
今后应助平常的可乐采纳,获得10
9秒前
李健应助从容的慕山采纳,获得10
9秒前
soar发布了新的文献求助10
10秒前
斯文香彤完成签到,获得积分10
11秒前
ilaragakki发布了新的文献求助10
12秒前
jyhk完成签到,获得积分10
12秒前
阿尔忒弥斯完成签到,获得积分10
12秒前
思源应助111采纳,获得10
12秒前
12秒前
田様应助fenghao采纳,获得10
13秒前
卷卷发布了新的文献求助10
13秒前
丘比特应助Mango采纳,获得10
13秒前
弥叶十厥发布了新的文献求助10
14秒前
14秒前
15秒前
cs发布了新的文献求助10
16秒前
16秒前
17秒前
是然宝啊完成签到,获得积分10
17秒前
万能图书馆应助liuxingyu采纳,获得10
18秒前
19秒前
典雅柚子发布了新的文献求助10
20秒前
linlin完成签到,获得积分10
21秒前
可爱的函函应助ilaragakki采纳,获得10
22秒前
魏淑辉完成签到 ,获得积分10
23秒前
shitaocameron发布了新的文献求助10
23秒前
空空完成签到,获得积分10
24秒前
tyt完成签到 ,获得积分10
24秒前
24秒前
filter发布了新的文献求助30
26秒前
机智的从霜完成签到 ,获得积分10
26秒前
高分求助中
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
Case Research: The Case Writing Process 300
Global Geological Record of Lake Basins 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141967
求助须知:如何正确求助?哪些是违规求助? 2792954
关于积分的说明 7804609
捐赠科研通 2449278
什么是DOI,文献DOI怎么找? 1303129
科研通“疑难数据库(出版商)”最低求助积分说明 626796
版权声明 601291